Pricing Log in Create free account
Friday 6 November 2026 Export QGEN’s income statement to Excel — free account

QIAGEN N.V.

QGEN Healthcare Diagnostics & Research

QIAGEN N.V.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 5.65% from fiscal 2024.

Revenue
+0.28%
EPS
+7.94%
Free cash flow
+30.5%
Total debt
+13.8%

Quarter to June 2026, against a year earlier

50.88 0.05 +0.10%
Market cap
$10.5B
P/E
26.1×
Fwd P/E
26.0×
Dividend yield
0.69%
F-score
8/9
Altman Z
3.94
Beneish M
−2.60
Dividend safety
66/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

QIAGEN N.V. (QGEN) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, QIAGEN N.V. (QGEN) trades at a price to free cash flow of 23.8×. Over the past ten years it has ranged from 14.9× (September 2022) to 1,299× (October 2020); the current reading is higher than 27% of that period. That is below the Diagnostics & Research industry median of 33.5× and above the Healthcare sector median of 21.1×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 23.0× 7.62%
FY2024 21.4× (39.97%)
FY2023 35.6× 71.97%
FY2022 20.7× (29.36%)
FY2021 29.3× (62.73%)
FY2020 78.6× (42.61%)
FY2019 137× 266.25%
FY2018 37.4× (15.06%)
FY2017 44.0× 71.32%
FY2016 25.7× (17.10%)

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 18.3× (10.77%)
Mar 2026 20.5× (10.75%)
Dec 2025 23.0× 12.13%
Sep 2025 20.5× (7.23%)
42 more quarters

Against its own ten years

Low 14.9× High 1,299×
Ten-year median 27.9×
Current reading's percentile 27

Price to free cash flow against peers

Company Price to free cash flow
GRAL GRAIL, Inc. compare n/m
GH Guardant Health, Inc. compare n/m
ICLR ICON PLC compare 18.1×
QGEN QIAGEN N.V. 23.8×
MEDP Medpace Holdings, Inc. compare 26.6×
RVTY Revvity Inc. compare 28.2×
CRL Charles River Laboratories International, Inc. compare 37.6×
BLLN BillionToOne, Inc. compare 156×
RDNT RadNet, Inc. compare 189×
Diagnostics & Research industry median 33.5×
Healthcare sector median 21.1×
Market median 14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on QGEN